Physical Medicine, Paris University Hospital, Paris, France.
Eur J Phys Rehabil Med. 2011 Jun;47(2):245-51.
Little is known about coccydynia in adolescents.
The aim of this study was to explore causes, clinical and imaging features and response to treatment of chronic coccydynia in adolescents.
This was a cohort study.
The study included patients followed up at a specialized consultation in a university hospital.
A series of 53 adolescent patients with chronic coccydynia were followed for 1-4 years. Investigations included dynamic X-ray films, with a magnetic resonance imaging scan of the coccyx in 26/53. Treatment was by coccygeal steroid injection or non-steroidal anti-inflammatory drugs (NSAIDs). Amitriptyline or coccygectomy were used as second-line treatment. Outcomes were assessed at a consultation two months after the treatment, then between one to four years later, by telephone interview, questionnaires and by a visual analogue scale (VAS). Fifty-one adult patients with coccydynia formed the control group.
In 20 cases (37.7%) the coccydynia was subsequent to trauma. Obesity was not a risk factor. Abnormal mobility was rarer and spicules more frequent compared to adult patients (P<0.001); 11/27 MRI scans showed a hypersignal within the disc or adjacent bone and 6/27 a hypersignal surrounding the tip of the coccyx (bursitis). Initial treatment was a coccygeal steroid injection for 41 patients and NSAIDs for 12. Ten were given amitriptyline and 3 a coccygectomy. At final assessment, there was no pain or almost no pain in 32/53 (60.4%), moderate pain and functional impairment in 12/53 (22.6%) and severe pain and functional impairment in 9/53 (17%).
Coccydynia in adolescents differs from coccydynia in adults. A MRI scan is helpful and should be obligatory for diagnosis. Prognosis is relatively good.
Our results should help clinicians manage this rare and debilitating condition.
青少年尾痛症知之甚少。
本研究旨在探讨青少年慢性尾痛症的病因、临床和影像学特征及治疗反应。
这是一项队列研究。
该研究纳入了在一所大学医院的专科门诊接受随访的患者。
对 53 例慢性尾痛症青少年患者进行了为期 1-4 年的随访。检查包括动态 X 射线片,26/53 例患者行尾骨磁共振成像扫描。治疗方法为尾骨皮质类固醇注射或非甾体抗炎药(NSAIDs)。阿米替林或尾骨切除术作为二线治疗。治疗后 2 个月、1 至 4 年后通过门诊随访、电话访谈、问卷调查和视觉模拟评分(VAS)进行评估。51 例成人尾痛症患者作为对照组。
20 例(37.7%)尾痛症继发于创伤。肥胖不是危险因素。与成人患者相比,异常活动较少,骨刺较常见(P<0.001);27 例 MRI 扫描中 11 例显示椎间盘或相邻骨内高信号,6 例显示尾骨尖端周围高信号(滑囊炎)。41 例初始治疗为尾骨皮质类固醇注射,12 例初始治疗为 NSAIDs。10 例给予阿米替林,3 例给予尾骨切除术。末次评估时,32/53 例(60.4%)无疼痛或几乎无痛,12/53 例(22.6%)中度疼痛和功能障碍,9/53 例(17%)重度疼痛和功能障碍。
青少年尾痛症与成人尾痛症不同。MRI 扫描有助于诊断,且应为必需检查。预后相对较好。
我们的研究结果应该有助于临床医生治疗这种罕见且使人衰弱的疾病。